Jin‐Fei Lin
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Inflammasome and immune disorders
Papers in
-
- RNA modifications and cancer 8
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 2
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Huai‐Qiang Ju (13 shared papers)Rui‐Hua Xu (12 shared papers)Ting Li (6 shared papers)Dan Xie (3 shared papers)Tian Tian (2 shared papers)Jiajun Li (1 shared paper)Zexian Liu (7 shared papers)Kai Yu (5 shared papers)
- Journals
- Nature Communications (3 papers)Signal Transduction and Targeted Therapy (3 papers)Oncogene (2 papers)Cancer Letters (1 paper)Frontiers in Human Neuroscience (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jin‐Fei Lin
22 papers receiving 1.5k citations
Jin‐Fei Lin's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 677
- Molecular Biology 924
- Pulmonary and Respiratory Medicine 222
- Immunology 124
- Oncology 126
Countries citing papers authored by Jin‐Fei Lin
This map shows the geographic impact of Jin‐Fei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Fei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Fei Lin more than expected).
Fields of papers citing papers by Jin‐Fei Lin
This network shows the impact of papers produced by Jin‐Fei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Fei Lin. The network helps show where Jin‐Fei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin‐Fei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer Hit paper breakdown → | 2020 | 496 |
| 2 | NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications Hit paper breakdown → | 2020 | 404 |
| 3 | Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis Hit paper breakdown → | 2022 | 241 |
| 4 | 2021 | 117 | |
| 5 | 2020 | 48 | |
| 6 | 2022 | 47 | |
| 7 | 2019 | 40 | |
| 8 | 2012 | 28 | |
| 9 | 2022 | 27 | |
| 10 | 2024 | 20 | |
| 11 | 2015 | 17 | |
| 12 | 2023 | 15 | |
| 13 | 2025 | 12 | |
| 14 | 2018 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2018 | 6 | |
| 17 | 2025 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2025 | 1 | |
| 20 | 2023 | 1 |
About Jin‐Fei Lin
Jin‐Fei Lin is a scholar working on Molecular Biology, Cancer Research, Immunology, Surgery and Epidemiology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer, Hypoxia, and Metabolism (4 papers), Multisensory perception and integration (3 papers), Cancer-related gene regulation (3 papers), Ferroptosis and cancer prognosis (2 papers), Olfactory and Sensory Function Studies (2 papers), Immune cells in cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (677 citations), Molecular Biology (924 citations), Pulmonary and Respiratory Medicine (222 citations), Immunology (124 citations) and Oncology (126 citations). Jin‐Fei Lin has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Huai‐Qiang Ju, Rui‐Hua Xu, Ting Li, Dan Xie, Tian Tian, Jiajun Li, Zexian Liu, Kai Yu, Junzhong Lin and Peishan Hu. Their work appears in journals such as Nature Communications, Signal Transduction and Targeted Therapy, Oncogene, Cancer Letters and Frontiers in Human Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.